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Abstract: A new tribenzamidomethyl hydrazine was synthesized and its IR, 
1
H NMR, 
 
13
C NMR and MS spectroscopic data are presented. 
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Many hydrazine derivatives are known to exhibit significant biological activity and several 
compounds with hydrazine moiety were shown to be effective for treatment of tuberculosis, 
Parkinson’s disease and hypertension [1]. There is evidence that some hydrazines displaying 
neuroprotective properties can be used as antidepressant drugs [2], while for some trisubstituted 
hydrazines antimicrobial effect was observed [3]. The hydrazine moiety has been used for 
modification of peptides as well. For example, novel building blocks for peptide modification have 
been designed and synthesized to obtain β-sheet tripeptide mimics that comprise the azapeptide 
modification at one end [4]. Azapeptides, hydrazine-based peptidomimetics, were found to be potent 
agents against hepatitis [5], AIDS [6] and SARS [7]. In addition, hydrazine derivatives have been used 
for derivatization of nanostructures [8]. Therefore, the synthesis of hydrazine derivatives is a matter of 
significant interest from both theoretical and practical perspectives. On the other hand, the promising 
usefulness of the benzamidomethyl derivatives as biologically active products [9-11] and their 
implication for pro-drug design [12-15] have been previously reported. Our good results with the 
benzamidomethylation of amines and hydrazides [16-18] using (benzamidomethyl)triethylammonium 
chloride (1), prompted us to synthesize some new products containing hydrazine and 
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benzamidomethyl moieties with an aim to obtain new compounds with potential biological activity. In 
this short note, the synthesis of a novel tribenzamidomethyl hydrazine is reported.  
Benzamidomethylation reaction of hydrazine, using 1 as a reagent, was performed smoothly in 
ethanol/aqueous media, under mild reaction conditions at ambient temperature (Scheme 1). The title 
compound (3) was obtained without using a catalyst. Crystals of the product were easily isolated by 
simple filtration and stored in a dark place at a temperature below 18 °C. 
Scheme 1. Synthetic route to the title compound 3. 
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The structure of the newly synthesized compound was confirmed by 
1
H NMR, 
13
C NMR, FTIR 
spectroscopy and high-resolution mass spectrometry as well.  
Synthesis 
Materials 
All the reagents and solvents were obtained from commercial sources and used without further 
purification. (Benzamidomethyl)triethylammonium chloride was prepared according to the literature 
method [19]. Synthetic reaction was monitored by thin-layer chromatography with visualization by 
UV-light or staining with iodine vapors. 
Instrumentation 
Melting points were determined on a Reichert heating plate and are uncorrected. NMR spectra were 
recorded on a Bruker 250 MHz instrument using DMSO-d6 as solvent and tetramethylsilane as internal 
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standard. Infrared spectra (KBr pellets) were measured on a Perkin-Elmer System 2000 FT-IR. The 
ESI mass spectra were recorded on a QTof premiere (Waters) equipped with an Acquity UPLC 
(Waters)." UPLC – Gradients and solvents: A = water + 0.1% formic acid; B = methanol + 0.1% 
formic acid; 0 min = 95% A; 2.5 min = 5% A, 6.5 min = 5% A; 6.6 min = 95% A, 8 min = 95% A. 
Synthesis of tribenzamidomethyl hydrazine (3) 
To a mixture of (benzamidomethyl)triethyl-ammonium chloride (465.1 mg, 1.72 mmol) in 8 mL of 
water and 0.2 mL of triethylamine, a solution of hydrazine dihydrochloride (59.8 mg, 0.57 mmol) in  
8 mL of ethanol was added. Afterwards, the reaction mixture was stirred overnight at room 
temperature. In this phase, colorless crystals were obtained, which were collected by vacuum filtration. 
The purification was performed by dissolving the product in ethanol and precipitation with water.  
Melting point of pure crystals: 123–125 °C. Typical yield 85%. 
FTIR (KBr, cm
−1
): v(N-H) 3294, 3359, Amide I 1642, Amide II 1542; 
1
H-NMR (250 MHz, DMSO-d6): δ/ppm 8.81 (t, J = 6.0 Hz, 1H, CONHCH2NHN, overlap), 8.78 (t,  
J = 6.0 Hz, 2H, CONHCH2NN, overlap) 7.37–7.88 (m, 15H, ArH), 4.51 (t, J = 5.0 Hz, 1H, NNH), 
4.36 (d, J = 6.0 Hz, 4H, CH2NN, overlap), 4.34 (t, J = 5.5 Hz, 2H, CH2NHN, overlap);  
13
C NMR (62.89 MHz, CDCl3): δ/ppm 167.34, 166.41 C=O; 55.68, 58.68 CH2; Ar: 134.41; 131.41, 
131.29, 128.28;  
HRMS (ESI, pos) m/z: 432.1900 (M+H)
+
; 454.1701 (M+Na)
+
. 
Acknowledgements 
We are grateful to the Macedonian Ministry of Education and Science (Contract 03-1586) and the 
Bulgarian National Science Fund (Contract BM-02/07) for financial support.  
References and Notes 
1.  Ragnarsson, U. Synthetic methodology for alkyl substituted hydrazines. Chem. Soc. Rev. 2001, 
30, 205–213. 
2.  Ling, L.; Urichuk, L.J.; Sloley, B.D.; Coutts, R.T.; Baker, G.B.; Shan, J.J.; Pang, P.K.T. Synthesis 
of N-propargylphenelzine and analogues as neuroprotective agents. Bioorg. Med. Chem. Lett. 
2001, 11, 2715–2717. 
3. Černuchová, P.; Vo-Thanh, G; Milata, V.; Loupy, A; Jantová, S.; Theiszová M. Utilization of 2-
ethoxymethylene-3-oxobutanenitrile in the synthesis of heterocycles possessing biological 
activity. Tetrahedron 2005, 61, 5379–5387. 
4. Rabong, C.; Jordis, U.; Phopase, J.B. NXO Building Blocks for Backbone Modification of 
Peptides and Preparation of Pseudopeptides. J. Org. Chem. 2010, 75, 2492–2500. 
5. Zhang, R.; Durkin, J.P.; Windsor, W.T. Azapeptides as inhibitors of the hepatitis C virus NS3 
serine protease. Bioorg. Med. Chem. Lett. 2002, 12, 1005–1008. 
Molbank 2010 M710 (Page 4) 
 
 
6. Raja, A.; Lebbos, J.; Kirkpatrick, P. Fresh from the Pipeline: Atazanavir sulphate. Nat. Rev. Drug 
Discov. 2003, 2, 857–858. 
7. Lee, T.W.; Cherney, M.M.; Huitema, C.; Liu, J.; James, K.E.; Powers, J.C.; Eltis, L.D.; James, 
M.N.G. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a 
substrate-like aza-peptide epoxide. J. Mol. Biol. 2005, 353, 1137–1151. 
8. Roubelakis, M.M.; Murata, Y.; Komatsu, K; Orfanopoulos, M. Efficient synthesis of open-cage 
fullerene derivatives having 16-membered-ring orifices. J. Org. Chem. 2007, 72, 7042–7045.  
9. Tiwari, K.A.; Singh, K.V.; Bajpai, A.; Shukla, G.; Singh, S.; Mishra, K.A. Synthesis and 
biological properties of 4-(3H)-quinazolone derivatives. Eur. J. Med. Chem. 2007, 42,  
1234–1238.  
10. Mai, A.; Artico, M.; Valente, S.; Cerbara, I.; Befani, O.; Turini, P.; Vedova, D.L.; Agostinelli, E. 
Synthesis and biochemical evaluation of (R)-5-acyloxymethyl- and (S)-5-acylaminomethyl-3-(1H-
pyrrol-1-yl)-2-oxazolidinones as new anti-monoamine oxidase (anti-MAO) agents. ARKIVOC 
2004, 2004, 32–43. 
11. Zlotin, G.S.; Sharova, V.I.; Luk`yanov, A.O. Chemical properties of N-(amidomethy)- and N-
(imidomethyl)glycine derivatives 2. Reactions at alkoxycarbonyl and carboxyl groups. Rus. 
Chem. Bul. 1996, 45, 1680–1687.  
12. Schioppacassi, G.; Morvillo, E.; Bruna, C.D.; Franceschi, G.; Foglio, M. In vitro and in vivo 
evaluation of benzamidomethyl-benzylpenicillinate (FI7303). A new 'repository' form. 
Chemotherapy 1978, 24, 338–342.  
13. Bundgaard, H.; Nielsen, N.M.; Buur, A. Aspirin prodrugs: synthesis and hydrolysis of 2-
acetoxybenzoate esters of various N-(hydroxyalkyl) amides. Int. J. Pharm. 1988, 44, 151–158. 
14. Moreira, R.; Calheiros, T.; Cabrita, J.; Mendes, E.; Pimentel, M.; Iley, J. Acyloxymethyl as a drug 
protecting group. Part 3. Tertiary O-Amidomethyl esters of penicillin G: Chemical hydrolysis and 
anti-bacterial activity. Pharm. Res. 1996, 13, 70–75. 
15. Getz, J.J.; Prankerd, R.J.; Sloan, K.B. Mechanism of hydrolysis of benzamidomethyl derivatives 
of phenols and its implications for prodrug design. J. Org. Chem. 1992, 57, 1702–1706. 
16. Popovski, E.; Klisarova, L.; Vikic-Topic, D. Benzamidomethylation with (benzamidomethyl)tri-
ethylammonium chloride. 2. A simple method for benzamidomethylation of thiols, amines and 
carboxylic acods. Molecules 2000, 5, 927–936.  
17.  Popovski, E. Synthesis of N-(N’-benoylhydrazinomethyl)benzamide. Molbank 2007, 2007, 
M525. 
18. Popovski, E. Synthesis of N-[N’-(2-hydroxy-2,2-diphenylacethyl)hydrazinomethyl]benzamide. 
Molbank 2007, 2007, M526. 
19.  Popovski, E.; Klisarova, L.; Vikic-Topic, D. Simple Method for Benzamidomethylation of 
Phenols in Water Solution. Synth. Commun. 1999, 29, 3451–3458. 
 
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
